OmniAb, Inc.
OABI • NASDAQ
OmniAb, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew W. Foehr, with a market cap of $217.2M.
Market Cap$217.2M
Employees106.0
CEOMatthew W. Foehr
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
OmniAb, Inc. FAQ
Common questions about OmniAb, Inc.
OmniAb, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $5.7M.
OmniAb, Inc. has approximately 106 employees.